🎉 We are excited to share that QIAGEN LLC has been recognized as a Best Place to Work for Disability Inclusion by the Disability Equality Index, receiving a top score! ✅ The Disability Equality Index is widely acknowledged as the most comprehensive assessment tool that helps companies build a roadmap of measurable and tangible actions toward disability inclusion and equality. The Index measures a range of criteria for disability inclusion, all of which are reflected at QIAGEN LLC and throughout our global QIAGEN organization. 🤝 Many thanks to all QIAGENers, who continuously work to create an inclusive and welcoming environment for all employees, ensuring everyone has an equal opportunity to thrive and make a difference!
Over ons
QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of December 31 2021 QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at www.qiagen.com.
- Website
-
http://www.qiagen.com
Externe link voor QIAGEN
- Branche
- Biotechnologisch onderzoek
- Bedrijfsgrootte
- 5.001 - 10.000 medewerkers
- Hoofdkantoor
- Venlo, Limburg
- Type
- Naamloze vennootschap
- Specialismen
- Life science research, Molecular diagnostics, Applied testing (forensics, food safety testing, veterinary medicine), Pharmaceutical research en bioinformatics
Locaties
Medewerkers van QIAGEN
Updates
-
The human body has trillions of microbes aiding digestion, boosting immunity, and influencing metabolism. So why not the same for plants and soil? Learn how manipulating plant microbiomes can help crop security 👉 https://lnkd.in/efbZTcBf
-
-
Whole genome sequencing of tuberculosis with no cell culture. Learn more 👉 https://lnkd.in/edtezyx7 Yes, it’s true, so we’ll say it again. The new QIAseq xHYB Mycobacterium tuberculosis Panel is designed using the seven major lineages of MTB and provides coverage of all AMR markers with no cell culture.
-
We are thrilled to partner with the Snow Molecular Anthropology Lab at the University of Montana to enhance the identification of human remains of Indigenous people and African Americans. Learn more 👉 https://lnkd.in/gFeFXxjw ✅ Our partnership drives the implementation of next-generation sequencing and forensic investigative genetic genealogy in identifying human remains. ✅ We provide instruments, kits and training for building the first Inidgenous-owned DNA database for the Blackfeet Nation and identifying human remains of African Americans who were part of the convict leasing system. ✅ This collaboration underlines our leading position in forensic applications and human identification, exemplifying our commitment to advancing forensic science and providing answers to victims and their families.
-
-
🌟 Gastrointestinal (GI) panels are transforming care for patients with suspected GI infections. They’re reducing diagnosis times, cutting down on invasive tests and ensuring peace of mind. 🔍 Curious about how they can support your practice? ✅ Learn more about these advancements through clinical cases and publication summaries at 👉 https://lnkd.in/evfh8SWu #Healthcare #GIPanels #PatientCare #ClinicalCases
-
In this week’s interview with BiotechTV, our CEO Thierry BERNARD describes latest sample, assay, and bioinformatics technologies that are powering life sciences and molecular diagnostics. He discusses the scientific and clinical advances underlying our focus areas: sample technologies, QuantiFERON, QIAstat-Dx, and digital PCR (dPCR). Watch the full interview to learn how these innovations are powering the future of research and healthcare 👉 https://lnkd.in/gAKWgWuq
-
Up to 13 million people in the US carry latent TB infection – and children are at increased risk for progression from infection to contagious active TB disease. Children are also commonly exposed to settings with a higher risk for TB transmission, like schools and childcare centers.
Deze content is hier niet beschikbaar
Open deze content en meer in de LinkedIn-app
-
At QIAGEN, we believe that our commitment to diversity and inclusion drives our success and innovation. By creating an environment where everyone feels accepted and valued, we empower our team to reach their highest potential. #pridemonth #LGBTQ #QIAversity #diversity #inclusion
-
-
🤔 Do you wish you had a smile as nice as a Neanderthal’s? Celebrate World Microbiome Day by discovering the surprisingly great teeth of these extinct people, and what they might teach us about the modern oral microbiome 👉 https://lnkd.in/eFi_5cth
Could the ancient oral microbiome be the key to improving modern health?
qiagen.com
-
From combating TB in Alaska to bringing new hope to lung cancer patients, our customers are heroes making a tangible impact on millions of lives. Read these stories and more in our Insights Magazine. 👉 https://lnkd.in/g2duU9kX
✅ Download the QIAGEN Insights Magazine 2024
https://flippingbook.com/